Halozyme
HALO
HALO
541 hedge funds and large institutions have $6.04B invested in Halozyme in 2025 Q2 according to their latest regulatory filings, with 88 funds opening new positions, 175 increasing their positions, 214 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
541
Holders Change
-1
Holders Change %
-0.18%
% of All Funds
7.25%
Holding in Top 10
3
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-66.67%
% of All Funds
0.04%
New
88
Increased
175
Reduced
214
Closed
80
Calls
$26.3M
Puts
$21.3M
Net Calls
+$5.06M
Net Calls Change
-$11.9M
Top Buyers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$74.2M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$61M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$51.3M |
| 4 |
Jane Street
New York
|
+$48.2M |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
+$45.8M |
Top Sellers
| 1 |
BlackRock
New York
|
-$202M |
| 2 |
JPMorgan Chase & Co
New York
|
-$74.9M |
| 3 |
NL
Nuveen LLC
Charlotte,
North Carolina
|
-$49.3M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$39.7M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$39.5M |
